Dashboard
Manage Tickers

XMTRXometry, Inc.

NASDAQ xometry.com


$ 15.72 $ -0.20 (-1.26 %)    

Wednesday, 22-Mar-2023 14:31:34 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 313.37 $ 2.41 (0.78 %)
DIA $ 325.93 $ 0.19 (0.06 %)
SPY $ 400.49 $ -0.24 (-0.06 %)
TLT $ 105.64 $ 1.02 (0.97 %)
GLD $ 182.04 $ 1.84 (1.02 %)
$ 15.93
$ 15.89
$ 15.70 x 300
$ 16.95 x 100
$ 15.24 - $ 16.10
$ 14.48 - $ 64.35
806,533
na
751.23M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-16-2023 12-31-2022 10-K
2 11-14-2022 09-30-2022 10-Q
3 08-11-2022 06-30-2022 10-Q
4 05-12-2022 03-31-2022 10-Q
5 03-18-2022 12-31-2021 10-K
6 11-10-2021 09-30-2021 10-Q
7 08-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

looking-into-xometrys-recent-short-interest
Looking Into Xometry's Recent Short Interest
03/03/2023 19:45:32

goldman-sachs-maintains-buy-on-xometry-lowers-price-target-to-30
Goldman Sachs Maintains Buy on Xometry, Lo...
03/03/2023 16:01:13

Goldman Sachs analyst Bruno Montanari maintains Xometry (NASDAQ:XMTR) with a Buy and lowers the price target from $57 to $30.

citigroup-maintains-buy-on-xometry-lowers-price-target-to-25
Citigroup Maintains Buy on Xometry, Lowers...
03/03/2023 14:36:43

Citigroup analyst Ronald Josey maintains Xometry (NASDAQ:XMTR) with a Buy and lowers the price target from $55 to $25.

ubs-maintains-neutral-rating-for-xometry-heres-what-you-need-to-know
UBS Maintains Neutral Rating for Xometry: ...
03/02/2023 17:00:21

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
03/02/2023 15:00:53

ubs-maintains-neutral-on-xometry-lowers-price-target-to-20
UBS Maintains Neutral on Xometry, Lowers P...
03/02/2023 14:45:29

UBS analyst Karl Keirstead maintains Xometry (NASDAQ:XMTR) with a Neutral and lowers the price target from $45 to $20.

analyst-expectations-for-xometrys-future
Analyst Expectations for Xometry's Future
03/02/2023 14:01:30

Core News & Articles
12 Consumer Discretionary Stocks Moving In...
03/02/2023 13:06:38

jp-morgan-downgrades-xometry-to-neutral-lowers-price-target-to-21
JP Morgan Downgrades Xometry to Neutral, L...
03/02/2023 10:16:21

JP Morgan analyst Cory Carpenter downgrades Xometry (NASDAQ:XMTR) from Overweight to Neutral and lowers the price target fro...

rbc-capital-downgrades-xometry-to-sector-perform-lowers-price-target-to-21
RBC Capital Downgrades Xometry to Sector P...
03/02/2023 10:15:25

RBC Capital analyst Matthew Hedberg downgrades Xometry (NASDAQ:XMTR) from Outperform to Sector Perform and lowers the price ...

nasdaq-down-75-points-bg-foods-shares-spike-higher
Nasdaq Down 75 Points; B&G Foods Shares Sp...
03/01/2023 19:30:04

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 75 points on Wednesday. The Dow ...

stocks-that-hit-52-week-lows-on-wednesday
Stocks That Hit 52-Week Lows On Wednesday
03/01/2023 18:30:01

  On Wednesday, 100 stocks hit new 52-week lows.

why-novavax-shares-are-trading-lower-by-around-28-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Novavax Shares Are Trading Lower By Ar...
03/01/2023 18:16:45

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval ...

Core News & Articles
12 Consumer Discretionary Stocks Moving In...
03/01/2023 17:31:23

dow-edges-higher-ism-manufacturing-pmi-rises-in-february
Dow Edges Higher; ISM Manufacturing PMI Ri...
03/01/2023 17:28:09

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 30 points on Wednesday. The Dow traded up 0...

us-stocks-edge-lower-dollar-tree-profit-beats-views
US Stocks Edge Lower; Dollar Tree Profit B...
03/01/2023 14:52:07

U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 30 points on Wednesday. Following th...

xometry-implemented-5-point-strategic-plan-with-increasing-focus-on-top-200-accounts-rapidly-expanding-the-marketplace-menu-furthering-international-expansion-and-growth-driving-adoption-of-new-products-and-aggressively-reducing-operating-expenses
Xometry Implemented 5-point Strategic Plan...
03/01/2023 12:16:08

xometry-expects-q1-revenue-100m-102m-fy23-revenue-470m-480m
Xometry Expects Q1 Revenue $100M-$102M, FY...
03/01/2023 12:14:03

xometry-q4-adj-eps-029-misses-023-estimate-sales-9820m-miss-10433m-estimate
Xometry Q4 Adj EPS $(0.29) Misses $(0.23) ...
03/01/2023 12:12:29

Xometry (NASDAQ:XMTR) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.23) by ...

earnings-scheduled-for-march-1-2023
Earnings Scheduled For March 1, 2023
03/01/2023 11:59:54

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenu...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

03/27/2023 Argo Blockchain plc (ARBK)
03/27/2023 Sotera Health Company (SHC)
03/28/2023 National Vision Holdings, Inc. (EYE)
04/03/2023 Allianz SE (ALIZY)
04/03/2023 Honda Motor Co., Ltd. (HMC)
04/03/2023 Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD)
04/03/2023 Ryvyl Inc. f/k/a GreenBox POS (RVYL)
04/04/2023 Atlassian Corporation (TEAM)
04/07/2023 PLDT Inc. (PHI)
04/11/2023 Caribou Biosciences, Inc. (CRBU)

NEW CASE INVESTIGATION

Iovance Biotherapeutics, Inc. (IOVA)